Showing 1711-1720 of 9132 results for "".
Drug Companies, Insurance Companies, Pharmacists, the Government, Doctors and…Oh, Patients!
https://practicaldermatology.com/topics/practice-management/drug-companies-insurance-companies-pharmacists-the-government-doctors-andoh-patients/21063/Ask An Expert: Establish Your Expertise
https://practicaldermatology.com/youngmd-connect/resident-resource-center/ask-an-expert-establish-your-expertise/21174/Viewpoints: When is it Enough?
https://practicaldermatology.com/topics/general-topics/viewpoints-when-is-it-enough/21104/As MOC concerns mount, one specialist is calling for a poll of dermatologists.Physician Spotlight
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight/21220/Pearls for Choosing and Initiating Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0309_18-php/22872/Members of the psoriasis panel at the 2009 South Beach Symposium last month offered insights on patient care.Hyperpigmentation in Darker Skin Types: A Review of Current Treatments
https://practicaldermatology.com/programs/practical-dermatology/hyperpigmentation-in-darker-skin-types-a-review-of-current-treatments/24217/Pigmentary disorders are a leading concern for patients and consumers worldwide.DermWireTV: Candela + Merz Aesthetics Partnership, COVID-19 Vaccines & Fillers, Almirall's Klisyri, MetSyn & PsO
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-candela-merz-aesthetics-partnership-covid-19-vaccines-and-fillers-almiralls-klisyri-metsyn-and-pso/19893/Klisyri® (tirbanibulin) ointment 1% from Almirall will be available for treatment of AKs by the end of this quarter; Ayman Grada, MD discusses. Are patients who have received dermal filler injections at risk for developing reactions to the COVID-19 vaccine? Joel L. Cohen, MD and Doris Day, MD weighAn Overview of Topical Therapies for Managing Pediatric AD
https://practicaldermatology.com/topics/atopic-dermatitis/an-overview-of-topical-ththerapies-for-managing-pediatric-ad/54375/Moisturization is foundational in AD management; no specific formulation has demonstrated superiority, and excessive bathing may worsen disease via increased transepidermal water loss. Topical corticosteroids and calcineurin inhibitors remain first-line due to strong efficacy data, cost-effectiveneTetracyclines: History and Current Formulation Review From a Dermatology Perspective
https://practicaldermatology.com/topics/general-topics/tetracyclines-history-and-current-formulation-review-from-a-dermatology-perspective/21233/Seborrheic Dermatitis Update: A Review of the Etiology and Treatment of Seborrheic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology/seborrheic-dermatitis-update-a-review-of-the-etiology-and-treatment-of-seborrheic-dermatitis/24003/Seborrheic dermatitis (SD) is an inflammatory skin condition that often involves flaky, erythematous patches on sebum-rich areas of the body such as the face and scalp.1 At least 50 million Americans have a form of seborrheic dermatitis on the scalp, more commonly known as dandruff. SD presents in a